Europe’s medicines regulator has recommended the suspension of more than 300 generic drug approvals and drug applications due to “unreliable” tests conducted by Indian contract research firm Micro Therapeutic Research Labs. The decision, announced by the European Medicines Agency on its website, is the latest blow for India’s drug-testing industry, which has run into a series of problems with international regulators in recent years.